Literature DB >> 3037585

A quantitative cerebral and whole body autoradiographic study of a intravenously administered benzodiazepine antagonist 3H-Ro 15-1788 in mice.

R d'Argy, A Persson, G Sedvall.   

Abstract

3H-Ro 15-1788, a benzodiazepine receptor antagonist, was injected IV into male and pregnant mice. Autoradiograms were prepared from sagittal sections of animals killed after 30 s to 48 h. In the adult animal there was a rapid and high initial accumulation of radioactivity in the brain as compared to other organs and tissues. The highest accumulation was found in cortical brain areas, such as the olfactory bulb and the frontal cortex. Cerebellar cortex, globus pallidus, amygdala, substantia nigra, colliculus, hippocampus and pons followed in rank order. The rate of decline of radioactivity was highest in the pons and lowest in the olfactory bulb. The initial disappearance of radioactivity from the cerebellum was higher than from the other brain regions. Ro 15-1788 was rapidly eliminated; 4 h after drug administration there was an almost complete clearance of radioactivity from all tissues. After 24 h no trace of activity remained in the animal. The distribution of radioactivity at later time points indicates that metabolites of Ro 15-1788 are eliminated by fecal, urinary and nasal secretion. In the fetus also there was an early accumulation of radioactivity in the central nervous system. The radioactivity in fetal organs was lower than in the mother at all time intervals.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3037585     DOI: 10.1007/BF00215472

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  11 in total

1.  Pharmacokinetics of the selective benzodiazepine antagonist Ro 15-1788 in man.

Authors:  U Klotz; G Ziegler; I W Reimann
Journal:  Eur J Clin Pharmacol       Date:  1984       Impact factor: 2.953

Review 2.  Benzodiazepine receptors.

Authors:  J G Richards; H Möhler
Journal:  Neuropharmacology       Date:  1984-02       Impact factor: 5.250

3.  The melanin affinity of chloroquine and chlorpromazine studied by whole body autoradiography.

Authors:  N G Lindquist; S Ullberg
Journal:  Acta Pharmacol Toxicol (Copenh)       Date:  1972

4.  Benzodiazepine receptor binding in vivo with [3H]-Ro 15-1788.

Authors:  N E Goeders; M J Kuhar
Journal:  Life Sci       Date:  1985-07-29       Impact factor: 5.037

5.  Kinetics and displacement of [11C]RO 15-1788, a benzodiazepine antagonist, studied in human brain in vivo by positron tomography.

Authors:  Y Samson; P Hantraye; J C Baron; F Soussaline; D Comar; M Mazière
Journal:  Eur J Pharmacol       Date:  1985-04-02       Impact factor: 4.432

6.  Central type benzodiazepine binding sites: a positron emission tomography study in the baboon's brain.

Authors:  P Hantraye; M Kaijima; C Prenant; B Guibert; J Sastre; M Crouzel; R Naquet; D Comar; M Maziere
Journal:  Neurosci Lett       Date:  1984-07-27       Impact factor: 3.046

7.  [11C-Ro15-1788 and 11C-flunitrazepam, two coordinates for the study by positron emission tomography of benzodiazepine binding sites].

Authors:  M Mazière; C Prenant; J Sastre; M Crouzel; D Comar; P Hantraye; M Kaïsima; B Guibert; R Naquet
Journal:  C R Seances Acad Sci III       Date:  1983

8.  [3H]Propyl beta-carboline-3-carboxylate as a selective radioligand for the BZ1 benzodiazepine receptor subclass.

Authors:  C Braestrup; M Nielsen
Journal:  J Neurochem       Date:  1981-08       Impact factor: 5.372

9.  Selective antagonists of benzodiazepines.

Authors:  W Hunkeler; H Möhler; L Pieri; P Polc; E P Bonetti; R Cumin; R Schaffner; W Haefely
Journal:  Nature       Date:  1981-04-09       Impact factor: 49.962

10.  Benzodiazepine antagonist Ro 15-1788: binding characteristics and interaction with drug-induced changes in dopamine turnover and cerebellar cGMP levels.

Authors:  H Möhler; W P Burkard; H H Keller; J G Richards; W Haefely
Journal:  J Neurochem       Date:  1981-09       Impact factor: 5.372

View more
  1 in total

Review 1.  Imaging of cerebral ischemia: from acute stroke to chronic disorders.

Authors:  May Nour; David S Liebeskind
Journal:  Neurol Clin       Date:  2013-10-23       Impact factor: 3.806

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.